Corona Remedies Pvt. Ltd. is a fast-growing Indian pharmaceutical company dedicated to developing high-quality, affordable, and patient-centric healthcare solutions. Established with a strong commitment to improving health outcomes, the company delivers trusted medicines across key therapeutic categories including cardiology, diabetology, gastroenterology, gynaecology, dermatology, paediatrics, and general medicine.
With a focus on research-driven product development, world-class manufacturing, and deep doctor–patient trust, Corona Remedies has built a strong presence in India’s highly competitive pharmaceutical market.
About the Company
Corona Remedies operates on the core philosophy of “Caring for Life”, ensuring easy access to effective medicines for people across urban and rural India. The company’s product portfolio spans:
- Prescription formulations
- OTC health solutions
- Nutraceuticals
- Specialty treatments
Its robust distribution network and medical engagement initiatives enable consistent outreach to healthcare professionals nationwide.
Key Strengths of Corona Remedies
1. Broad Therapeutic Portfolio
Corona Remedies offers diversified treatments in chronic and acute segments, ensuring strong penetration across multiple medical specialties.
2. Quality-Driven Manufacturing
Its manufacturing facilities follow WHO-GMP standards, ensuring consistent quality, safety, and efficacy.
3. Strong R&D Focus
The company invests significantly in formulation research, stability studies, and innovation to bring advanced therapies to market.
4. Nationwide Presence
With a large field force and distribution network, Corona Remedies serves hospitals, clinics, and pharmacies across India.
5. Patient-Centric Approach
Educational awareness programs, doctor engagement, and community health initiatives highlight its commitment to public wellness.
Market Presence & Growth
Corona Remedies continues to grow at a strong pace, supported by strategic brand-building, product innovation, and expansion across therapeutic areas. The company has emerged as a reliable healthcare partner for doctors, chemists, and patients.
With its blend of scientific excellence, ethical practices, and market-driven strategies, Corona Remedies is positioned as a trusted name in India’s pharmaceutical landscape.
Key Strengths of Meesho
- ✔ Wide product assortment across lifestyle, fashion, home, beauty, and essentials
- ✔ Affordable pricing attracting value-conscious Indian consumers
- ✔ Strong logistics network ensuring pan-India delivery
- ✔ Built-in tools for sellers including catalog listing, order management, payments, and marketing support
- ✔ AI-driven personalization improving product discovery and user experience
Corona Remedies continues to grow at a strong pace, supported by strategic brand-building, product innovation, and expansion across therapeutic areas. The company has emerged as a reliable healthcare partner for doctors, chemists, and patients.
With its blend of scientific excellence, ethical practices, and market-driven strategies, Corona Remedies is positioned as a trusted name in India’s pharmaceutical landscape.
Corona Remedies Ltd IPO Timetable
| Particular | Date |
| IPO Open Date | 08 Dec 2025 |
| IPO Close Date | 10 Dec 2025 |
| Allotment Date | 11 Dec 2025 |
| IPO Listing Date | 15 Dec 2025 |
Corona Remedies Ltd IPO Details
| Issue Type | Book building IPO |
| Face Value | Rs. 10 Per Equity Share |
| IPO Price | Rs. 1008 to 1062 Per Equity Share |
| Market Lot | 14 Share |
| ISIN Code | |
| Listing At | NSE, BSE |
| Issue Size | Rs. 655.37 Crore. |
Corona Remedies Ltd IPO Lot Size
| Application | Lots | Shares | Amount |
| Minimum | 1 | 14 | Rs. 14868 |
| Maximum | 13 | 182 | Rs. 193284 |
| Small HNI (Minimum) | 14 | 196 | Rs. 208152 |
| Big HNI (Minimum) | 67 | 952 | Rs. 1011024 |
Corona Remedies Ltd IPO Allotment Status
Click Here To Check IPO Allotment Status Corona Remedies Ltd IPO
Click Here To Get ASBA Forms Corona Remedies Ltd IPO
Company Financials :
| Particular | 31 March 2025 | 31 March 2024 | 31 March 2023 |
| Total Assets | 929.86 | 830.58 | 595.02 |
| Total Revenue | 1202.35 | 1020.93 | 891.10 |
| Profit After Tax | 149.43 | 90.50 | 84.93 |
Company Promoters:
The company’s promoters are Dr. Kirtikumar Laxmidas Mehta, Niravkumar Kirtikumar Mehta and Ankur Kirtikumar Mehta.
Objects of this Issue:
- Miscellaneous
Registrar & Company Details
| Company Contact Information | IPO Registrar |
| Corona Remedies Ltd. CORONA House, C – Mondeal Business Park Near Gurudwara S. G. Highway Thaltej Ahmedabad, Gujarat, 380059 Phone: +91 79 4023 3000 Email: complianceofficer@coronaremedies.com Website: https://www.coronaremedies.com/ | Bigshare Services Pvt.Ltd. Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com Website: https://ipo.bigshareonline.com/IPO_Status.html |
Risk Discloer :-Investing in Initial Public Offerings (IPOs) involves significant market risks. The information provided in this blog post is for educational and informational purposes only and should not be treated as investment advice or a recommendation to subscribe to any IPO. Investors must carefully read the Red Herring Prospectus (RHP), company financials, and all risk factors before investing.
IPO allotment is not guaranteed, and the listing price may differ from expectations due to market demand, business fundamentals, and overall market conditions. Newly listed companies may experience high volatility in the initial days of trading. Past performance of other IPOs does not indicate or assure future results.
Investors should evaluate their risk appetite, financial objectives, and seek independent professional advice before making any investment decisions.
